Oklahoma City, OK3 Active Studies

Substance Use Disorder Clinical Trials in Oklahoma City, OK

Find 3 actively recruiting substance use disorder clinical trials in Oklahoma City, OK. Connect with local research sites and explore new treatment options.

3
Active Trials
1
Sponsors
522
Enrolling

Recruiting Substance Use Disorder Studies in Oklahoma City

About Substance Use Disorder Clinical Trials in Oklahoma City

Substance use disorder is a condition where the use of substances leads to health issues, disability, and failure to meet responsibilities. It encompasses alcohol, opioid, stimulant, and other drug addictions. Treatment includes behavioral therapy, medication-assisted treatment, and support programs.

There are currently 3 substance use disorder clinical trials recruiting participants in Oklahoma City, OK. These studies are seeking a combined 522 participants. Research is being sponsored by University of Oklahoma. Clinical trial participation is free and participants receive study-related medical care at no cost.

Substance Use Disorder Clinical Trials in Oklahoma City — FAQ

Are there substance use disorder clinical trials in Oklahoma City?

Yes, there are 3 substance use disorder clinical trials currently recruiting in Oklahoma City, OK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Oklahoma City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oklahoma City research site will contact you about next steps.

Are clinical trials in Oklahoma City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oklahoma City studies also compensate for your time and travel.

What substance use disorder treatments are being tested?

The 3 active trials in Oklahoma City are testing new therapies including novel drugs, biologics, and treatment approaches for substance use disorder.

Data updated July 13, 2026 from ClinicalTrials.gov